This exclusive PRO content provides investors with our monthly ETF picks, monthly newsletter, as well as fundamental and technical analysis on ETFs and much more.
These exclusive PRO tools provide investors with up to date fund flow data, power rankings, downloadable ETF holdings and much more.
ETFdb.com’s proprietary ETF Screener allows users to filter and screen all ETFs based on customized parameters.
Switch from mutual funds to ETFs by identifying the “best fit” ETFs based on underlying holdings.
Compare ETF themes based on popular financial metrics, including fund flows, return, AUM, expense ratio, dividend yield and issuer revenue.
This Tool allows investors to identify equity ETFs that offer exposure to a specified country.
Investors can compare two ETFs head-to-head, making it easy to decide between potential ETF investments.
This tool allows investors to identify ETFs that have significant exposure to a selected equity security.
See which overarching investment topics are poised to shape the financial markets in 2018.
Find out which events are likely to move markets in a significant manner.
Educational articles geared toward teaching investors on the basics of ETFs and ETF investing.
A collection of resources, Q&A Interviews with industry pros, and ETF categories to help investors research, gain industry insights and evaluate ETFs.
Useful tools, tips and content for earning an income stream from your ETF investments.
Insights and analysis on various equity focused ETF sectors
Insights and analysis on energy focused ETFs
Insights and analysis on Real Estate, Commodities, and other alternative investment focused ETFs
Insights and analysis on leveraged and inverse ETFs
View the most popular ETFS based on AUM
Content focused on identifying potential gaps in advisory businesses, and isolate trends that may impact how advisors do business in the future.
Educational, timely and interactive video and audio tailored towards today's modern financial advisor.
Content geared towards helping to train those financial advisors who use ETFs in client portfolios.
Artificial Intelligence is an area of computer science that focuses the creation of intelligent machines that work and react like humans. See our independently curated list of ETFs to play this theme here.
Blockchain technology allows for a recorded incorruptible decentralized digital ledger of all kinds of transactions to be distributed on a network. See our independently curated list of ETFs to play this theme here.
ESG Investing is the consideration of environmental, social and governance factors alongside financial factors in the investment decision–making process. See our independently curated list of ETFs to play this theme here.
Marijuana is often referred to as weed, MJ, herb, cannabis and other slang terms. It’s the green or gray dried flowers of Cannabis sativa. See our independently curated list of ETFs to play this theme here.
In the tables below, ETFdb.com presents recommended exchange traded fund (ETF) alternatives to the mutual fund FBIOX. These recommendations are powered by ETFdb's Mutual Fund to ETF Converter tool.
How ETFdb.com has selected ETF alternatives to FBIOX: The mutual fund FBIOX has been benchmarked by Fidelity Investments against an index, MSCI US Investable Market Biotechnology Index, in its fund prospectus. The ETF alternatives to FBIOX listed below consist of (1) ETFs which track MSCI US Investable Market Biotechnology Index, and (2) ETFs which track other indexes in the same ETFdb.com Category as MSCI US Investable Market Biotechnology Index.
There are no ETFs linked to MSCI US Investable Market Biotechnology Index.
The following table presents exchange traded funds linked to indexes in the same ETFdb.com Category as MSCI US Investable Market Biotechnology Index.
|Symbol||ETF Name||Assets||YTD||Expense Ratio|
|BBH||VanEck Vectors Biotech ETF||$409,266.04||13.83%||0.35%|
|IHE||iShares U.S. Pharmaceuticals ETF||$388,655.57||6.12%||0.43%|
|XBI||SPDR S&P Biotech ETF||$4,017,133.27||17.20%||0.35%|
|XPH||SPDR S&P Pharmaceuticals ETF||$242,376.90||11.14%||0.35%|
|IBB||iShares Nasdaq Biotechnology ETF||$8,017,934.88||13.19%||0.47%|
|FBT||First Trust Amex Biotechnology Index||$2,802,564.39||14.82%||0.56%|
|PJP||Invesco Dynamic Pharmaceuticals ETF||$464,287.69||5.53%||0.57%|
|PPH||VanEck Vectors Pharmaceutical ETF||$196,896.83||9.25%||0.36%|
|IYH||iShares U.S. Healthcare ETF||$2,343,738.18||6.70%||0.43%|
|XLV||Health Care Select Sector SPDR Fund||$19,386,085.64||6.01%||0.13%|
|VHT||Vanguard Healthcare ETF||$9,277,387.57||7.32%||0.10%|
|IXJ||iShares Global Healthcare ETF||$2,082,065.88||6.64%||0.47%|
|FXH||First Trust Health Care AlphaDEX Fund||$2,115,726.75||10.31%||0.63%|
|RYH||Invesco S&P 500® Equal Weight Health Care ETF||$721,361.29||11.26%||0.40%|
|PBE||Invesco Dynamic Biotechnology & Genome ETF||$263,247.36||9.58%||0.59%|
|PTH||Invesco DWA Healthcare Momentum ETF||$207,280.78||14.19%||0.60%|
|IHF||iShares U.S. Healthcare Providers ETF||$984,601.48||10.42%||0.43%|
|IHI||iShares U.S. Medical Devices ETF||$3,206,284.72||11.85%||0.43%|
|XHE||SPDR S&P Health Care Equipment ETF||$602,416.71||14.51%||0.35%|
|PSCH||Invesco S&P SmallCap Health Care ETF||$848,813.23||13.61%||0.29%|
|XHS||SPDR S&P Health Care Services ETF||$130,608.09||12.75%||0.35%|
|CHNA||Loncar China BioPharma ETF||$2,157.33||12.51%||0.79%|
|FHLC||Fidelity MSCI Health Care Index ETF||$1,613,982.93||7.33%||0.08%|
|ARKG||ARK Genomic Revolution Multi-Sector ETF||$315,088.10||20.89%||0.75%|
|BBP||Virtus LifeSci Biotech Products ETF||$28,538.49||16.75%||0.79%|
|BBC||Virtus LifeSci Biotech Clinical Trials ETF||$26,909.49||9.99%||0.79%|
|SBIO||ALPS Medical Breakthroughs ETF||$181,831.98||17.52%||0.50%|
|JHMH||John Hancock Multi-Factor Health Care ETF||$67,476.81||8.50%||0.40%|
|CNCR||Loncar Cancer Immunotherapy ETF||$43,260.80||14.52%||0.79%|
|GNRX||VanEck Vectors Generic Drugs ETF||$3,330.28||7.42%||0.55%|
|LNGR||Global X Longevity Thematic ETF||$16,971.54||12.42%||0.50%|
|BTEC||Principal Healthcare Innovators Index ETF||$54,025.56||18.95%||0.42%|
|FTXH||First Trust Nasdaq Pharmaceuticals ETF||$4,178.64||8.69%||0.60%|
|IEHS||iShares Evolved U.S. Healthcare Staples ETF||$4,309.84||9.74%||0.18%|
|IEIH||iShares Evolved U.S. Innovative Healthcare ETF||$5,097.52||8.23%||0.18%|
|KMED||KraneShares Emerging Market Healthcare Index ETF||$4,331.77||6.39%||0.79%|
|CHIH||Global X MSCI China Health Care ETF||$1,566.14||15.55%||0.65%|
Smart beta exchange-traded funds (ETFs) have become increasingly popular over the past several years. In fact, BlackRock projects that smart beta ETFs will grow at a 20% annual pace to $1 trillion in assets under management by 2020.
Smart beta exchange-traded funds (ETFs) have become a popular way for investors to target specific portfolio outcomes like reduced risk, enhanced returns or higher income at a lower cost than actively managed funds.
With the rise of bonds ETFs investors now have more ways than ever before to improve, as well as damage, their fixed income portfolios.